Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengdan Xu

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Current Medical Research and Opinion|October 26, 2016
Effects of lercanidipine hydrochloride versus felodipine sustained-release on day-to-day home blood pressure variabilityMengdan Xu, Ying Wu, Hao Wang, et al.
Current Medical Research and Opinion|November 27, 2014
Lercanidipine hydrochloride versus felodipine sustained-release for mild-to-moderate hypertension: a multi-center, randomized clinical trialYing Wu, Mengdan Xu, Hao Wang, et al.
ACS Nano|December 5, 2025
Clinically Translatable Injectable Hydrogel Platform for Dual Intraoperative Elevation and Postoperative Healing in Endoscopic Submucosal DissectionMengdan Xu, Wei Peng, Guangqiu Yu, et al.
Journal of Nanobiotechnology|July 1, 2026
Cholesterol-depleted macrophage membrane-coated nano-rapamycin for targeted atherosclerosis therapyRuru Zhang, Yan Liu, Zeyuan Cao, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Current Medical Research and Opinion|October 26, 2016
Effects of lercanidipine hydrochloride versus felodipine sustained-release on day-to-day home blood pressure variabilityMengdan Xu, Ying Wu, Hao Wang, et al.
Current Medical Research and Opinion|November 27, 2014
Lercanidipine hydrochloride versus felodipine sustained-release for mild-to-moderate hypertension: a multi-center, randomized clinical trialYing Wu, Mengdan Xu, Hao Wang, et al.
ACS Nano|December 5, 2025
Clinically Translatable Injectable Hydrogel Platform for Dual Intraoperative Elevation and Postoperative Healing in Endoscopic Submucosal DissectionMengdan Xu, Wei Peng, Guangqiu Yu, et al.
Journal of Nanobiotechnology|July 1, 2026
Cholesterol-depleted macrophage membrane-coated nano-rapamycin for targeted atherosclerosis therapyRuru Zhang, Yan Liu, Zeyuan Cao, et al.
Pageof 5